Spero Therapeutics (SPRO) director receives RSU and 20,000-share option grant
Filing Impact
Filing Sentiment
Form Type
4
Rhea-AI Filing Summary
Spero Therapeutics director John C. Pottage Jr. reported equity awards consisting of both restricted stock units and stock options. He received 10,000 shares of Common Stock as restricted stock units that each convert into one share when they vest on June 23, 2027, subject to his continued service. Following this award, he directly holds 85,000 shares of common stock. He was also granted a stock option for 20,000 shares of common stock with an exercise price of $2.15 per share, expiring on June 23, 2036, which will vest and become exercisable in full on June 23, 2027 if he continues to serve as a director.
Positive
- None.
Negative
- None.
Insider Trade Summary
2 transactions reported
Mixed
2 txns
Insider
Pottage John C Jr
Role
null
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 20,000 | $0.00 | -- |
| Grant/Award | Common Stock | 10,000 | $0.00 | -- |
Holdings After Transaction:
Stock Option (right to buy) — 20,000 shares (Direct, null);
Common Stock — 85,000 shares (Direct, null)
Footnotes (1)
- Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting. The RSUs vest on June 23, 2027, subject to the Reporting Person's continued service through the applicable vesting date. The shares underlying this option will vest and become exercisable in full on June 23, 2027 subject to the Reporting Person's continued service as a director through the vesting date.
Key Figures
RSU grant: 10,000 shares
Shares held after grant: 85,000 shares
Stock option size: 20,000 shares
+2 more
5 metrics
RSU grant
10,000 shares
Restricted stock units granted June 23, 2026
Shares held after grant
85,000 shares
Common stock directly held following RSU award
Stock option size
20,000 shares
Underlying common shares for new option grant
Option exercise price
$2.15 per share
Exercise price of stock option granted June 23, 2026
Option expiration
June 23, 2036
Expiration date of 20,000-share stock option
Key Terms
restricted stock units ("RSUs"), Stock Option (right to buy), vest, exercise price, +1 more
5 terms
restricted stock units ("RSUs") financial
"Consists of restricted stock units ("RSUs"). Each RSU represents the right to receive one share of common stock upon vesting."
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
Stock Option (right to buy) financial
"Stock Option (right to buy)"
vest financial
"The RSUs vest on June 23, 2027, subject to the Reporting Person's continued service through the applicable vesting date."
A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.
exercise price financial
"conversion_or_exercise_price": "2.1500""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
expiration date financial
"expiration_date": "2036-06-23T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
What insider transactions did Spero Therapeutics (SPRO) disclose for John C. Pottage Jr.?
Spero Therapeutics disclosed that director John C. Pottage Jr. received 10,000 restricted stock units and a stock option for 20,000 shares at $2.15 per share, both granted on June 23, 2026 and subject to future vesting conditions.
When do the new Spero Therapeutics (SPRO) restricted stock units for John C. Pottage Jr. vest?
The 10,000 restricted stock units granted to John C. Pottage Jr. vest on June 23, 2027. Each unit converts into one share of common stock, provided he continues to serve through that vesting date, aligning the award with ongoing board service.
What are the key terms of John C. Pottage Jr.’s new Spero Therapeutics (SPRO) stock option?
John C. Pottage Jr. received a stock option for 20,000 shares of common stock at an exercise price of $2.15 per share. The option vests in full on June 23, 2027, subject to continued service, and expires on June 23, 2036 if not exercised earlier.